In 2018 the pharmaceutical market showed active development. The total volume of drug consumption in the retail and hospital segments increased by 21% in UAH, by 19% – in dollar terms and by 4% – in bulk. The increase in monetary terms was mainly due to inflation, increased consumption in packages and the redistribution of consumption towards more expensive drugs.
Among the main trends in the retail market, we can note an increase in the share of sales of dietary supplements, prescription drugs, as well as an increase in the share of generic medicines.
According to forecasts, in the coming years, the market will continue to show double digit growth in monetary terms. Optimistic forecasts for the development of the pharmaceutical market allow us to expect that, following the results of 2020, Ukraine will again be able to enter the Pharmerging Markets group, promising emerging markets that are an attractive segment for international investors.
Ukraine is actively introducing international approaches to the ethics and legality of doing business for pharmaceutical companies, which must be taken into account by all players in this market. The first trend concerns the introduction from 2020 of automation of the exchange of information between tax authorities. Thanks to this, the State Fiscal Service of Ukraine (DFS) will have access to a global database of the activities of the company and its divisions / affiliates virtually around the world. Thus, it will be able to receive information online, about the countries where company pays taxes, where its production facilities are located, and will be able to track the supply chain from production to the moment goods arrive in Ukraine.
We have experience in cooperation with many pharmaceutical companies in Ukraine, as well as with pharmacy chains throughout the country, therefore, we can offer you both cooperation in the export of any pharmaceutical products manufactured in Ukraine, and the sale of imported products in Ukraine.
We want to draw your attention to the production of Dietary supplements. At the moment, we are engaged in supporting the Ukrainian company, which produces products exclusively from natural raw materials and medicinal plants. The sold product range is more than 60 items, more than 100 products are registered.
Due to the high biological activity and a harmonious combination of product components, each drug has an intensive beneficial effect on the body and its systems (digestive, respiratory, sexual, excretory, nervous, circulatory, lymphatic, endocrine, immune, musculoskeletal, integumentary) in each case.
The management of the manufacturer wishes to expand the market for its products outside of Ukraine and is ready for negotiations with partners from other countries. We invite you to cooperation, as We see the potential in the development of this direction and obtaining high profits for all cooperating parties.